Assessment and management of bone health in women with oestrogen receptor-positive breast cancer receiving endocrine therapy: Position statement of the Endocrine Society of Australia, the Australian and New Zealand Bone & Mineral Society, the Australasian Menopause Society and the Clinical Oncology Society of Australia

Grants

Funding Acknowledgements

The authors would like to thank the ESA Council (chair Associate Professor Warrick Inder), the ANZBMS Council (chair Professor Emma Duncan during the writing and reviewing of this report), the ANZBMS Therapeutics Committee (chair Professor Richard Prince), the ANZBMS Densitometry Committee (chair Associate Professor Nicholas Pocock), the AMS board members, the AMS Executive Director and AMS Past Presidents Doctors Jane Elliott and Anna Fenton, and the COSA council (chair Professor Phyllis Butow) for their support, expert reviews and valuable contributions to this manuscript.